Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranes.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1995-06-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0005-2736(95)00053-6PMID 7794962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity.

  1995cited by this paper
• Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells.

  1992cited by this paper
• Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.

  1990cited by this paper
• Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships.

  1990cited by this paper
• Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

  1989cited by this paper
• Preparation of mammalian plasma membranes by aqueous two-phase partition.

  1989cited by this paper
• Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

  1989cited by this paper
• Preparation of mammalian plasma membranes by aqueous two-phase partition.

  1989cited by this paper
• High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

  1977cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Cancer Therapeutic Applications of ENOX2 Proteins

  2012cites this paper
• ENOX2 (tNOX) and Cancer

  2012cites this paper
• The ENOX Protein Family

  2012cites this paper
• A hypothesis for the minimal overall structure of the mammalian plasma membrane redox system

  2003cites this paper
• A hypothesis for the minimal overall structure of the mammalian plasma membrane redox system

  2003cites this paper
• Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.

  2002cites this paper
• Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients

  2002cites this paper
• Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.

  2001cites this paper
• New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells

  2001influential citation
• NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms.

  2001cites this paper
• Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion.

  2001cites this paper
• Plasma Membrane NADH-Oxidoreductase System: A Critical Review of the Structural and Functional Data

  2000cites this paper
• Aqueous two-phase partition applied to the isolation of plasma membranes and Golgi apparatus from cultured mammalian cells.

  2000cites this paper
• Cell Membrane Redox Systems and Transformation

  2000cites this paper
• High-Capacity Redox Control at the Plasma Membrane of Mammalian Cells: Trans-Membrane, Cell Surface, and Serum NADH-Oxidases

  2000cites this paper
• Novel sulphonamide derivatives for the treatment of cancer

  2000cites this paper
• The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity.

  1999cites this paper
• Synthesis and cytotoxic activity of N-(2-pyridylsulfenyl)urea derivatives. A new class of potential antineoplastic agents.

  1999cites this paper
• Plasma Membrane Redox Systems and their Role in Biological Stress and Disease

  1998cites this paper
• Mode of action of the anticancer quassinoids--inhibition of the plasma membrane NADH oxidase.

  1998cites this paper
• Aqueous two-phase partition and detergent precipitation of a drug-responsive NADH oxidase from the HeLa cell surface.

  1998cites this paper
• The Sulfonylurea-Inhibited NADH Oxidase Activity of HeLa Cell Plasma Membranes has Properties of a Protein Disulfide–Thiol Oxidoreductase with Protein Disulfide–Thiol Interchange Activity

  1998cites this paper
• A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells.

  1998cites this paper
• NADH Oxidase: A Multifunctional Ectoprotein of the Eukaryotic Cell Surface

  1998cites this paper
• Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.

  1998cites this paper
• Is the Drug-Responsive NADH Oxidase of the Cancer Cell Plasma Membrane a Molecular Target for Adriamycin?

  1997cites this paper
• Effect of the quassinoids glaucarubolone and simalikalactone D on growth of cells permanently infected with feline and human immunodeficiency viruses and on viral infections.

  1997cites this paper
• Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.

  1997cites this paper
• Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients.

  1997cites this paper
• A Circulating Form of NADH Oxidase Activity Responsive to the Antitumor Sulfonylurea N-4-(methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) Specific to Sera from Cancer Patients

  1997cites this paper
• A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients.

  1997cites this paper
• Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.

  1996cites this paper
• Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines.

  1996cites this paper
• Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells.

  1996cites this paper
• The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.

  1995cites this paper
• NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.

  1995cites this paper